Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6362098Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2025
Linked Award Amount
$2.8M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#3,749
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Matthew L Freedman as a PI. Multi-PI records show the full award amount for context.
- 4R01CA262577-04R01Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies$1.3Maward amount
- 5R01CA251555-05R01Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches$675.1Kaward amount
- 1R01CA300092-01R01Mapping the epigenetic dynamics of prostate cancer progression: integrating liquid biopsies and single-cell epigenomics for early detection of lineage plasticity and clinical decision-making$627.5Kaward amount
- $186.6Kaward amount
Award organization
Organizations that administered FY2025 awards listing Matthew L Freedman as a PI.
FY2025 award administered by Dana-Farber Cancer Institute (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardDana-Farber Cancer Institute
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4834
- 2024Entered Top 25% NationallyRanked #4834
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Matthew L Freedman.
Mark M. Pomerantz
Dana-Farber Cancer Institute
5
shared awards
Andre Bergman
Dana-Farber Cancer Institute
3
shared awards
Wilbert Zwart
Dana-Farber Cancer Institute
3
shared awards
Alexander Gimelbrant
Dana-Farber Cancer Institute
2
shared awards
Alexander Gusev
Dana-Farber Cancer Institute
2
shared awards
Bogdan Pasaniuc
Dana-Farber Cancer Institute
2
shared awards
Eliezer M Van Allen
Dana-Farber Cancer Institute
2
shared awards
Himisha Beltran
Dana-Farber Cancer Institute
2
shared awards
Mary-ellen Taplin
Dana-Farber Cancer Institute
2
shared awards
Steven P. Balk
Dana-Farber Cancer Institute
2
shared awards